2026-01-26 - Analysis Report
**Company Overview**
Merck & Co., Inc. (MRK) is a global healthcare company that develops, manufactures, and markets a wide range of pharmaceuticals and vaccines.

**Return Rate Comparison**

* Cumulative return of review stock (MRK): 70.39%
* Cumulative return of comparison stock (S&P 500, VOO): 126.41%
* Divergence (simply the difference in cumulative return on the last day of the data): -56.30 (relative divergence: 28.20%)

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 33.0% | 15.3% | 21.0% | 0.7 | 182.1B |
| 2017-2019  | 39.0% | 15.3% | 14.0% | 0.7 | 216.8B |
| 2018-2020  | 29.0% | 24.7% | 5.0% | 0.7 | 195.0B |
| 2019-2021  | -1.0% | 24.7% | -66.0% | 0.6 | 191.4B |
| 2020-2022  | 41.0% | 22.9% | 34.0% | 0.5 | 277.1B |
| 2021-2023  | 49.0% | 19.2% | 29.0% | 0.3 | 272.3B |
| 2022-2024  | 18.0% | 25.3% | -12.0% | 0.3 | 248.5B |
| 2023-2025  | -11.0% | 40.0% | -86.0% | 0.3 | 262.9B |

**Recent Stock Price Fluctuations**

|  | Value |
| --- | --- |
| Close | $108.18 |
| Last-market | {'price': 108.18, 'previousClose': 109.18, 'change': -0.92} |
| 5-day SMA | $109.35 |
| 20-day SMA | $108.51 |
| 60-day SMA | $99.90 |

**RSI, PPO Index Indicators**

* Market Risk Indicator (MRI): 0.70
* RSI: 54.82
* PPO: -0.45
* Recent (20 days) relative divergence change: -2.40 (worsening)
* 7-day Rank change: 0 (flat)
* 7-day Dynamic Expected Return change: 0.00 (flat)
* Expected Return: -4.60%

**Recent News & Significant Events**

* [2026-01-22] Merck Stock Capital Return Hits $91 Bil - Trefis (news.google.com)
* [2026-01-25] Merck (MRK) Ends Acquisition Talks with Revolution Medicines Valued at $30 Billion - Intellectia AI (news.google.com)
* [2026-01-25] Merck & Co., Inc. $MRK Shares Acquired by Sector Gamma AS - MarketBeat (news.google.com)
* [2025-12-30] FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential - Yahoo Finance (news.google.com)
* [2026-01-15] Is Merck Stock A Trap At $110? - Forbes (news.google.com)
* [2026-01-20] New Analyst Forecast: $MRK Given $120 Price Target - Quiver Quantitative (news.google.com)

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.90 (~Buy)
- Opinions: 27
- Target Price (avg/high/low): 115.33 / 135.00 / 83.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-11-05 | 2.32 | 17.28 B$ |
| 2025-08-05 | 1.76 | 15.81 B$ |
| 2025-05-02 | 2.01 | 15.53 B$ |
| 2024-11-06 | 1.25 | 16.66 B$ |
| 2025-11-05 | 1.25 | 16.66 B$ |

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $17.28B | 77.69% |
| 2025-06-30 | $15.81B | 77.50% |
| 2025-03-31 | $15.53B | 77.98% |
| 2024-12-31 | $15.62B | 75.50% |
| 2024-09-30 | $16.66B | 75.51% |

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $51.85B | 11.16% |
| 2025-06-30 | $48.99B | 9.04% |
| 2025-03-31 | $48.34B | 10.51% |
| 2024-12-31 | $46.31B | 8.08% |
| 2024-09-30 | $44.50B | 7.09% |

**Comprehensive Analysis (Summary of previous items)**
Based on the provided data, MRK is experiencing a negative divergence from the S&P 500, with a cumulative return of 70.39% compared to 126.41%. However, the company's historical analysis shows a mixed performance, with periods of high growth and periods of decline. The recent stock price fluctuations indicate a slight downward trend, and the RSI, PPO, and Market Risk Indicator suggest a moderate risk level. Additionally, the recent news and significant events suggest that the company is facing challenges, including a fast-tracked FDA regulation. The analyst opinions indicate a buy consensus, but with a relatively low mean rating. Overall, MRK's performance is mixed, and investors should exercise caution when making investment decisions.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.